Hedge Fund - OrbiMed Advisors
Enliven Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $156,643,708 | 3.73% | 7,959,538 | $ |
| 2 | 2024 - Q4 (2024-12-31) | $179,089,605 | 3.68% | 7,959,538 | $ |
| 3 | 2024 - Q3 (2024-09-30) | $203,286,601 | 3.69% | 7,959,538 | $ |
| 4 | 2024 - Q2 (2024-06-30) | $186,014,403 | 3.67% | 7,959,538 | $ |
| 5 | 2024 - Q1 (2024-03-31) | $158,280,765 | 2.89% | 8,998,338 | $ |
| 6 | 2023 - Q4 (2023-12-31) | $124,536,998 | 2.48% | 8,998,338 | $ |
| 7 | 2023 - Q3 (2023-09-30) | $122,917,297 | 2.61% | 8,998,338 | $ |
| 8 | 2023 - Q2 (2023-06-30) | $183,656,079 | 3.32% | 8,998,338 | $ |
| 9 | 2023 - Q1 (2023-03-31) | $197,017,065 | 3.86% | 8,996,213 | $ |
The displayed share prices are average quarterly stock market prices.